Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease | Zendy

Brian Mc Ardle | Zendy; Tushar Shukla | Zendy; Graham Nichol | Zendy; Robert A. deKemp | Zendy; Jordan Bernick | Zendy; Ann Guo | Zendy; Siok Ping Lim | Zendy; Ross A. Davies | Zendy; Haissam Haddad | Zendy; Lloyd Duchesne | Zendy; Paul Hendry | Zendy; Roy G. Masters | Zendy; Heather J. Ross | Zendy; Michael R. Freeman | Zendy; Karen Y. Gulenchyn | Zendy; Normand Racine | Zendy; Dennis P. Humen | Zendy; François Bénard | Zendy; Terrence D. Ruddy | Zendy; Benjamin J.W. Chow | Zendy; Lisa Mielniczuk | Zendy; Jean N. DaSilva | Zendy; Linda Garrard | Zendy; George A. Wells | Zendy; Rob Beanlands | Zendy; Lyall Higginson | Zendy; Thierry Mesana | Zendy; Heikki Ukkonen | Zendy; Keiichiro Yoshinaga | Zendy; Julie Renaud | Zendy; Ran Klein | Zendy; May Aung | Zendy; William J. Kostuk | Zendy; Gerald Wisenberg | Zendy; Michel White | Zendy; R.M. Iwanochko | Zendy; Lynda L. Mickleborough | Zendy; Beth L. Abramson | Zendy; David A. Latter | Zendy; André Lamy | Zendy; Ernest L. Fallen | Zendy; Geoffrey Coates | Zendy

Open Access

Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease

Author(s) -

Brian Mc Ardle,

Tushar Shukla,

Graham Nichol,

Robert A. deKemp,

Jordan Bernick,

Ann Guo,

Siok Ping Lim,

Ross A. Davies,

Haissam Haddad,

Lloyd Duchesne,

Paul Hendry,

Roy G. Masters,

Heather J. Ross,

Michael R. Freeman,

Karen Y. Gulenchyn,

Normand Racine,

Dennis P. Humen,

François Bénard,

Terrence D. Ruddy,

Benjamin J.W. Chow,

Lisa Mielniczuk,

Jean N. DaSilva,

Linda Garrard,

George A. Wells,

Rob Beanlands,

Lyall Higginson,

Thierry Mesana,

Heikki Ukkonen,

Keiichiro Yoshinaga,

Julie Renaud,

Ran Klein,

May Aung,

William J. Kostuk,

Gerald Wisenberg,

Michel White,

R.M. Iwanochko,

Lynda L. Mickleborough,

Beth L. Abramson,

David A. Latter,

André Lamy,

Ernest L. Fallen,

Geoffrey Coates

Publication year - 2016

Publication title -

circulation cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.584

H-Index - 99

eISSN - 1942-0080

pISSN - 1941-9651

DOI - 10.1161/circimaging.115.004331

Subject(s) - medicine , hazard ratio , revascularization , positron emission tomography , fluorodeoxyglucose , myocardial infarction , ischemic cardiomyopathy , confidence interval , cardiology , coronary artery disease , randomized controlled trial , radiology , heart failure , ejection fraction

Whether viability imaging can impact long-term patient outcomes is uncertain. The PARR-2 study (Positron Emission Tomography and Recovery Following Revascularization) showed a nonsignificant trend toward improved outcomes at 1 year using an F-18-fluorodeoxyglucose positron emission tomography (PET)-assisted strategy in patients with suspected ischemic cardiomyopathy. When patients adhered to F-18-fluorodeoxyglucose PET recommendations, outcome benefit was observed. Long-term outcomes of viability imaging-assisted management have not previously been evaluated in a randomized controlled trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research